ATE441406T1 - Verbesserung der bildqualität im auge - Google Patents
Verbesserung der bildqualität im augeInfo
- Publication number
- ATE441406T1 ATE441406T1 AT05759460T AT05759460T ATE441406T1 AT E441406 T1 ATE441406 T1 AT E441406T1 AT 05759460 T AT05759460 T AT 05759460T AT 05759460 T AT05759460 T AT 05759460T AT E441406 T1 ATE441406 T1 AT E441406T1
- Authority
- AT
- Austria
- Prior art keywords
- image quality
- mind
- improved image
- zeaxanthin
- mixtures
- Prior art date
Links
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 abstract 4
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 abstract 2
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 abstract 2
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 abstract 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 abstract 2
- 239000001656 lutein Substances 0.000 abstract 2
- 235000012680 lutein Nutrition 0.000 abstract 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 abstract 2
- 229960005375 lutein Drugs 0.000 abstract 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 abstract 2
- 235000010930 zeaxanthin Nutrition 0.000 abstract 2
- 239000001775 zeaxanthin Substances 0.000 abstract 2
- 229940043269 zeaxanthin Drugs 0.000 abstract 2
- 230000004075 alteration Effects 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Eye Examination Apparatus (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04015189 | 2004-06-29 | ||
| PCT/EP2005/006168 WO2006002735A1 (en) | 2004-06-29 | 2005-06-08 | Improvement of image quality in the eye |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE441406T1 true ATE441406T1 (de) | 2009-09-15 |
Family
ID=35782481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05759460T ATE441406T1 (de) | 2004-06-29 | 2005-06-08 | Verbesserung der bildqualität im auge |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20080045605A1 (OSRAM) |
| EP (1) | EP1761254B1 (OSRAM) |
| JP (1) | JP5074184B2 (OSRAM) |
| KR (1) | KR20070027649A (OSRAM) |
| CN (1) | CN101094666B (OSRAM) |
| AT (1) | ATE441406T1 (OSRAM) |
| DE (1) | DE602005016405D1 (OSRAM) |
| ES (1) | ES2331083T3 (OSRAM) |
| WO (1) | WO2006002735A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1853239A1 (en) * | 2005-02-11 | 2007-11-14 | DSMIP Assets B.V. | Use of zeaxanthin for the treatment of diseases of the peripheral retina |
| AT503329A1 (de) | 2006-03-02 | 2007-09-15 | Omnica Gmbh | Verfahren zur herstellung einer zusammensetzung, welche zumindest ein xantophyll enthält |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6218436B1 (en) * | 1993-06-28 | 2001-04-17 | The Howard Foundation | Pharmaceutically active carotenoids |
| US5382714A (en) * | 1994-03-17 | 1995-01-17 | The Catholic University Of America | Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof |
| US5827652A (en) * | 1995-10-31 | 1998-10-27 | Applied Food Biotechnology, Inc. | Zeaxanthin formulations for human ingestion |
| FR2749758B1 (fr) * | 1996-06-12 | 1998-08-07 | Oenobiol Sa Lab | Composition a activite bronzante et photoprotectrice et ses applications esthetiques |
| WO1997048388A1 (en) * | 1996-06-17 | 1997-12-24 | The Board Of Trustees Of The University Of Illinois | Method of retarding and ameliorating central nervous system and eye damage |
| US6075058A (en) * | 1998-12-12 | 2000-06-13 | Tufts University | Compositions for increased bioavailability of carotenoids |
| US6712466B2 (en) * | 2001-10-25 | 2004-03-30 | Ophthonix, Inc. | Eyeglass manufacturing method using variable index layer |
| ES2299687T3 (es) * | 2002-01-30 | 2008-06-01 | Dsm Ip Assets B.V. | Luteina/zeaxantina para la proteccion contra el encandilamiento. |
| CN1481804A (zh) * | 2002-12-17 | 2004-03-17 | 无锡杰西医药科技有限公司 | 防治白内障、黄斑变性等眼病的配方及其使用方法 |
-
2005
- 2005-06-08 CN CN2005800202695A patent/CN101094666B/zh not_active Expired - Fee Related
- 2005-06-08 AT AT05759460T patent/ATE441406T1/de not_active IP Right Cessation
- 2005-06-08 DE DE602005016405T patent/DE602005016405D1/de not_active Expired - Lifetime
- 2005-06-08 US US11/629,997 patent/US20080045605A1/en not_active Abandoned
- 2005-06-08 KR KR1020067027745A patent/KR20070027649A/ko not_active Ceased
- 2005-06-08 WO PCT/EP2005/006168 patent/WO2006002735A1/en not_active Ceased
- 2005-06-08 ES ES05759460T patent/ES2331083T3/es not_active Expired - Lifetime
- 2005-06-08 JP JP2007519638A patent/JP5074184B2/ja not_active Expired - Fee Related
- 2005-06-08 EP EP05759460A patent/EP1761254B1/en not_active Expired - Lifetime
-
2011
- 2011-03-23 US US13/064,404 patent/US20110172313A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070027649A (ko) | 2007-03-09 |
| EP1761254A1 (en) | 2007-03-14 |
| JP5074184B2 (ja) | 2012-11-14 |
| US20080045605A1 (en) | 2008-02-21 |
| WO2006002735A1 (en) | 2006-01-12 |
| EP1761254B1 (en) | 2009-09-02 |
| CN101094666B (zh) | 2010-09-29 |
| ES2331083T3 (es) | 2009-12-21 |
| DE602005016405D1 (de) | 2009-10-15 |
| JP2008505137A (ja) | 2008-02-21 |
| CN101094666A (zh) | 2007-12-26 |
| US20110172313A1 (en) | 2011-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4442241A3 (en) | Retinol replacement in skin treatment | |
| IL172700A (en) | Methods for making neutralizing and cross-activating antibodies against kir2dl and drugs that include them for use in assessing antibody toxicity | |
| WO2012038512A3 (en) | Composition comprising sod, lutein and zeaxanthin | |
| CR9994A (es) | Vacuna terapéutica | |
| WO2012125830A3 (en) | Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control | |
| CL2008000806A1 (es) | Compuestos derivados de aza piridopirimidinona, con actividad agonista de hm74a; procedimiento de preparacion de dichos compuestos; composicion farmaceutico que las comprende; y su uso para preparar medicamentos para el tratamiento de enferemedades ateroscleroticas, dislipidemias, alzheimer, diabetes, entre otras. | |
| EA201001283A1 (ru) | Комбинация витамина d и 25-гидроксивитамина d3 | |
| CY1108794T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου | |
| EP3653205A3 (en) | Oxymethazoline for topical ophthalmic administration and uses thereof | |
| MY208400A (en) | Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (ror) and pharmaceutical uses thereof | |
| WO2018169282A3 (ko) | Atpif1을 함유하는 당뇨 치료용 약학조성물 | |
| DK2111125T3 (da) | Flydende formuleringer indeholdende carotinoider | |
| PH12019500949A1 (en) | Ror-gamma modulators | |
| MX2007001943A (es) | Nuevos compuestos biaromaticos activadores de los receptores del tipo receptor activado del proliferador de peroxisoma (ppar) y su uso en composiciones cosmeticas o farmaceuticas. | |
| Musa et al. | Nutritional Factors: benefits in glaucoma and ophthalmologic pathologies | |
| MX2019003725A (es) | Glicinato de metformina, composiciones farmaceuticas que comprenden la misma, y metodos de uso de la misma. | |
| Feng et al. | Cytoprotective effect of lacritin on human corneal epithelial cells exposed to benzalkonium chloride in vitro | |
| WO2015048503A3 (en) | N-arylmethyl sulfonamide negative modulators of nr2a | |
| WO2020142607A3 (en) | Uv screening and antioxidant composition and use thereof | |
| ATE441406T1 (de) | Verbesserung der bildqualität im auge | |
| Ahn et al. | Tat-ATOX1 inhibits streptozotocin-induced cell death in pancreatic RINm5F cells and attenuates diabetes in a mouse model | |
| WO2012143857A8 (en) | Combination of carotenoid, phytooestrogen and vitamin c for moisturizing the skin | |
| PH12022550938A1 (en) | Products and methods using sonication to increase bioactivity of soy peptides | |
| WO2007029121A3 (en) | Novel cyclopent-2-en-1-one derivatives which are ppar receptor modulators, and use thereof in pharmaceutical or cosmetic compositions | |
| CY1111361T1 (el) | Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |